Denosumab for Treating Periprosthetic Osteolysis.

NCT02299817 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Osteolysis

Interventions

DRUG: Denosumab
DRUG: Placebo

Sponsor

Olof Skoldenberg

Collaborators

[object Object]